$425.28
5.901.41%
At close: Aug 18, 5:00 PM EST
$425.28
5.901.41%
After Hours: 4:00 PM EST
Amgen Inc
AMGNNASDAQ
Dividend: The dividend Ex-Date is in 3 days
Amgen Earnings & Forecasts
Amgen (AMGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Amgen Guidance
Amgen (AMGN) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $22.3 - $23.5, compared to a consensus EPS estimate of $22.39. Amgen also guided revenue in the range of $38.2B - $39.4B for the period.
Compared to prior guidance, Amgen raised its EPS outlook from a previous range of $21.7 - $23.1. On the revenue side, the company raised its revenue forecast from a prior range of $37.1B - $38.5B.
Amgen has issued 16 guidance updates between November 3, 2022 and August 4, 2026. During this period, the company raised its outlook 7 times, reflecting management's growing confidence in business performance.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $5.60 | $4.76 | $4.75 | $5.01 |
| Actual | $6.29 | $5.15 | $5.29 | $5.64 |
| Surprise | +12.3% | +8.19% | +11.4% | +12.6% |
| Revenue | ||||
| Estimate | $9.42B | $8.55B | $9.46B | $8.96B |
| Actual | $10.05B | $8.62B | $9.87B | $9.56B |
| Surprise | +6.67% | +0.79% | +4.25% | +6.71% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $5.78 | $5.79 | $5.42 | $6.24 |
| Revenue | ||||
| Consensus | $9.99B | $10.24B | — | — |
